What gene therapy is used for Huntington's disease?
Updated: Oct 5
Gene therapy for Huntington's disease (HD) focuses on addressing the mutated HTT gene, responsible for producing toxic proteins that damage brain neurons. A prominent strategy under development involves gene silencing techniques, such as RNA interference (RNAi). This method delivers small RNA fragments that bind to the mutant HTT mRNA, effectively reducing the production of harmful proteins. Another approach utilizes viral vectors to introduce therapeutic DNA, aiming to modify or inhibit the mutated gene directly, which could potentially slow or halt the progression of Huntington's disease. While these therapies are still undergoing clinical trials, they show great promise in treating this debilitating neurodegenerative disorder.
Got more to add on this topic? Share your thoughts in the comments below!
Keep exploring with Gene Tech Times
Free guide: subscribe to the Gene Tech Times Briefing on our homepage and get Every FDA-Approved Gene Therapy at a Glance in your inbox.
Watch: 30-second gene therapy Shorts on Gene Tech Times Academy.
Read: The Cheat Codes of Our Genes, real stories of mutations that make some people immune to disease.
New to gene therapy? Start with The Life-Changing Power of Gene Therapy.
As an Amazon Associate, Gene Tech Times earns from qualifying purchases.
Comments